28416580|t|A TSPO ligand attenuates brain injury after intracerebral hemorrhage.
28416580|a|Intracerebral hemorrhage (ICH) is a devastating disease without effective treatment. After ICH, the immediate infiltration of leukocytes and activation of microglia are accompanied by a rapid up-regulation of the 18-kDa translocator protein (TSPO). TSPO ligands have shown anti-inflammatory and neuroprotective properties in models of CNS injury. In this study, we determined the impact of a TSPO ligand, etifoxine, on brain injury and inflammation in 2 mouse models of ICH. TSPO was up-regulated in Iba1(+) cells from brains of patients with ICH and in CD11b(+)CD45(int) cells from mice subjected to collagenase-induced ICH. Etifoxine significantly reduced neurodeficits and perihematomal brain edema after ICH induction by injection of either autologous blood or collagenase. In collagenase-induced ICH mice, the protection of etifoxine was associated with reduced leukocyte infiltration into the brain and microglial production of IL-6 and TNF-a. Etifoxine improved blood-brain barrier integrity and diminished cell death. Notably, the protective effect of etifoxine was abolished in mice depleted of microglia by using a colony-stimulating factor 1 receptor inhibitor. These results indicate that the TSPO ligand etifoxine attenuates brain injury and inflammation after ICH. TSPO may be a viable therapeutic target that requires further investigations in ICH.-Li, M., Ren, H., Sheth, K. N., Shi, F.-D., Liu, Q. A TSPO ligand attenuates brain injury after intracerebral hemorrhage.
28416580	2	6	TSPO	GeneOrGeneProduct	12257
28416580	25	37	brain injury	DiseaseOrPhenotypicFeature	D001927
28416580	44	68	intracerebral hemorrhage	DiseaseOrPhenotypicFeature	D002543
28416580	70	94	Intracerebral hemorrhage	DiseaseOrPhenotypicFeature	D002543
28416580	96	99	ICH	DiseaseOrPhenotypicFeature	D002543
28416580	161	164	ICH	DiseaseOrPhenotypicFeature	D002543
28416580	290	310	translocator protein	GeneOrGeneProduct	12257
28416580	312	316	TSPO	GeneOrGeneProduct	12257
28416580	319	323	TSPO	GeneOrGeneProduct	12257
28416580	348	360	inflammatory	DiseaseOrPhenotypicFeature	D007249
28416580	405	415	CNS injury	DiseaseOrPhenotypicFeature	D002493
28416580	462	466	TSPO	GeneOrGeneProduct	12257
28416580	475	484	etifoxine	ChemicalEntity	C002125
28416580	489	501	brain injury	DiseaseOrPhenotypicFeature	D001927
28416580	506	518	inflammation	DiseaseOrPhenotypicFeature	D007249
28416580	524	529	mouse	OrganismTaxon	10090
28416580	540	543	ICH	DiseaseOrPhenotypicFeature	D002543
28416580	545	549	TSPO	GeneOrGeneProduct	706
28416580	570	574	Iba1	GeneOrGeneProduct	199
28416580	599	607	patients	OrganismTaxon	9606
28416580	613	616	ICH	DiseaseOrPhenotypicFeature	D002543
28416580	624	629	CD11b	GeneOrGeneProduct	16409
28416580	632	636	CD45	GeneOrGeneProduct	19264
28416580	653	657	mice	OrganismTaxon	10090
28416580	671	682	collagenase	ChemicalEntity	D017364
28416580	691	694	ICH	DiseaseOrPhenotypicFeature	D002543
28416580	696	705	Etifoxine	ChemicalEntity	C002125
28416580	728	741	neurodeficits	DiseaseOrPhenotypicFeature	D001927
28416580	760	771	brain edema	DiseaseOrPhenotypicFeature	D001929
28416580	778	781	ICH	DiseaseOrPhenotypicFeature	D002543
28416580	835	846	collagenase	ChemicalEntity	D017364
28416580	851	862	collagenase	ChemicalEntity	D017364
28416580	871	874	ICH	DiseaseOrPhenotypicFeature	D002543
28416580	875	879	mice	OrganismTaxon	10090
28416580	899	908	etifoxine	ChemicalEntity	C002125
28416580	1004	1008	IL-6	GeneOrGeneProduct	16193
28416580	1013	1018	TNF-a	GeneOrGeneProduct	21926
28416580	1020	1029	Etifoxine	ChemicalEntity	C002125
28416580	1130	1139	etifoxine	ChemicalEntity	C002125
28416580	1157	1161	mice	OrganismTaxon	10090
28416580	1195	1231	colony-stimulating factor 1 receptor	GeneOrGeneProduct	12978
28416580	1275	1279	TSPO	GeneOrGeneProduct	12257
28416580	1287	1296	etifoxine	ChemicalEntity	C002125
28416580	1308	1320	brain injury	DiseaseOrPhenotypicFeature	D001927
28416580	1325	1337	inflammation	DiseaseOrPhenotypicFeature	D007249
28416580	1344	1347	ICH	DiseaseOrPhenotypicFeature	D002543
28416580	1349	1353	TSPO	GeneOrGeneProduct	12257
28416580	1429	1432	ICH	DiseaseOrPhenotypicFeature	D002543
28416580	1487	1491	TSPO	GeneOrGeneProduct	12257
28416580	1510	1522	brain injury	DiseaseOrPhenotypicFeature	D001927
28416580	1529	1553	intracerebral hemorrhage	DiseaseOrPhenotypicFeature	D002543
28416580	Positive_Correlation	D017364	D002543	No
28416580	Association	D002543	199	No
28416580	Association	706	D002543	Novel
28416580	Positive_Correlation	706	199	Novel
28416580	Association	12257	D002493	No
28416580	Association	12257	D002543	Novel
28416580	Association	12257	D007249	No
28416580	Association	12257	D001927	No
28416580	Association	12257	C002125	No
28416580	Association	C002125	12978	Novel
28416580	Positive_Correlation	C002125	21926	Novel
28416580	Positive_Correlation	C002125	16193	Novel
28416580	Negative_Correlation	C002125	D001929	Novel
28416580	Negative_Correlation	C002125	D002543	Novel
28416580	Negative_Correlation	C002125	D007249	Novel
28416580	Negative_Correlation	C002125	D001927	Novel